GLP-1 medications like Ozempic and Mounjaro rose to fame for their ability to treat Type 2 diabetes, but their weight loss potential is what really skyrocketed their popularity
These are designed to complement the effects of tirzepatide and semaglutide
An investigation from Farshbaf-Khalili et al., in Iran (2022), in a triple-blind, randomized controlled trial, examined the effects of curcumin on oxidative stress markers in postmenopausal women 4060 years of age
El seguro cubrir los medicamentos GLP-1 aprobados por la FDA
So it makes so much sense there
Moreover, SGLT2is have been shown to reduce the incidence of cardiovascular and kidney disease in people with and without diabetes [5, 6], suggesting that these medications should be considered for prevention of cardiovascular and kidney disease, irrespective of HbA 1c levels